Impax Asset Management Group PLC Elanco Animal Health Inc Transaction History

Impax Asset Management Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$25.29 - $29.45 $8.11 Million - $9.44 Million	-320,627 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$25.62 - $34.96 $1.35 Million - $1.84 Million	-52,600 Reduced 14.09%	320,627 $8.53 Million
Q2 2019 Aug 13, 2019	BUY	$31.11 - $34.79 $2.54 Million - $2.84 Million	81,500 Added 27.94%	373,227 $12.6 Million
Q4 2018 Feb 14, 2019	BUY	$29.63 - $34.5 $8.41 Million - $9.8 Million	284,000 Added 3675.42%	291,727 $9.2 Million
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $263,490 - $279,640	7,727 New	7,727 $270,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.